Johnson & Johnson is predicting $3.5 billion in sales of its COVID-19 vaccine in 2022, this represents a 46% jump in sales. The company has taken a lot of flak since it first started to market its vaccine. The uptake for its shot has not fared well compared to its much-touted rivals. The company said it would take a more […]
